ABSTRACT
Introduction
The treatment of hard tissue defects, especially those of bone and cartilage, induced by infections or tumors remains challenging. Traditional methods, including debridement with systematic chemotherapy, have shortcomings owing to their inability to eliminate infections and high systematic toxicity.
Area covered
This review comprehensively summarizes and discusses the current applications of 3D-printed porous tantalum (3D-P-p-Ta), a novel drug delivery strategy, in drug delivery systems to repair hard tissue defects, as well as the limitations of existing data and potential future research directions.
Expert opinion
Drug delivery systems have advanced medical treatments, with the advantages of high local drug concentration, long drug-release period, and minimal systematic toxicity. Due to its excellent biocompatibility, ideal mechanical property, and anti-corrosion ability, porous tantalum is one of the most preferable loading scaffolds. 3D printing allows for freedom of design and facilitates the production of regular porous implants with high repeatability. There are several reports on the application of 3D-P-p-Ta in drug delivery systems for the management of infection- or tumor-associated bone defects, yet, to the best of our knowledge, no reviews have summarized the current research progress.
Article Highlights
Hard tissue defects, including critical bone and osteochondral defects, of various causes remain challenging for orthopedic surgeons since they are difficult to treat or eliminate their recurrence.
Due to its excellent corrosion resistance, histocompatibility, mechanical properties which are similar to those of human cancellous bone, excellent bone integration ability, and personalized printing characteristics, 3D-P-p-Ta is considered as the most ideal orthopedic implant material presently available.
3D-P-p-Ta drug loading can be achieved using several methods, such as dip-coating, surface modification, packaging with hydrogel, so as to obtain excellent drug delivery capability.
At present, the drug delivery research using 3D-P-p-Ta has included anti-infection, anti-tumor, as well as bone and cartilage promotion.
Drug dose optimization design and clinical transformation application warrant further improvement.
Declaration of interest
The authors have no relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties.
Reviewer disclosures
Peer reviewers on this manuscript have no relevant financial or other relationships to disclose.
Abbreviation
DDSdrug delivery system
CADcomputer-aided design
3D-P-p-Ta3D printed porous tantalum
MSSAmethicillin-sensitive Staphylococcus aureus
CaPcalcium phosphide
TGFtransforming growth factor
PCLpolycaprolactone
BMPbone morphogenetic protein
BMSCsbone marrow mesenchymal stem cells.